Clinical Trials Browser

Completed × Prostatic Neoplasms × CTLA-4 Antigen × Clear all

NCT02601014 2022-02-03

STARVE-PC

Phase 2 Completed

32 enrolled 15 charts

Prostatic Neoplasms

NCT00064129 2020-07-30

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms